Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1231.65
-13.85 (-1.11%)
< Home < Back

Dr. Reddy's Lab gets EIR for formulations Srikakulum plant in Andhra Pradesh

Date: 14-05-2020

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for formulations Srikakulum plant (SEZ) Unit I, Andhra Pradesh, indicating closure of the audit and the inspection classification of this facility is determined as No Action Indicated (NAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.